YOLFTbeta
Athens Medical C.S.A.

Athens Medical C.S.A.

IATR · AT · Healthcare / Medical Care Facilities

1.38EUR-0.01 (-0.72%)

Price History

Full chart

Market Stats

Previous Close1.39
Open1.38
Day Range1.38 – 1.40
52-Week Range1.50 – 2.19
Volume4.00K
Market Cap132.71M
P/E (TTM)0.00
Forward P/E11.07
EPS-0.06
Dividend Yield0.00%
Beta0.79
50-Day Avg1.58
200-Day Avg1.76

About

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions. In addition, the company operates wellness and prevention centers; and offers medical education, training, and practice services. The company was founded in 1983 and is based in Athens, Greece.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Vasilios G. Apostolopoulos
  • Employees0
  • Headquarters5-7 Distomou Street, Athens, Greece, 15125, Greece
  • Websitehttps://www.iatriko.gr

Leadership

  • Dr. Georgios V. ApostolopoulosPresident of the Board · b. 1941
  • Dr. Vasilios G. ApostolopoulosCEO & Executive Director
  • Mr. Christos G. ApostolopoulosFirst Executive Vice President of the Board
  • Mr. Petros D. AdamopoulosChief Financial Officer
  • Mr. Panagiotis Ch. KatsichtisChief Accountant
  • Mr. Fanis NezeritisHead of Technical Department
  • Theodora AnagnostopoulouDepartment Head of Investor Relations
  • Mr. Thodoris PapafotopoulosHuman Resource Manager · b. 1961
  • Mr. Georgios ZerdilasExecutive Director
  • Mr. Georgios BoutsioukosExecutive Director

Financials

Income Statement

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue148.87M158.09M167.35M169.27M182.75M197.27M187.50M226.00M233.42M258.36M269.85M275.75M
Growth (%)-+6.19%+5.85%+1.15%+7.96%+7.95%-4.95%+20.53%+3.28%+10.69%+4.44%+2.19%
Cost of Revenue134.05M131.26M130.06M132.57M136.94M149.52M147.01M168.21M176.61M191.81M209.08M219.61M
Gross Profit14.82M26.83M37.29M36.70M45.81M47.75M40.49M57.79M56.81M66.56M60.76M56.14M
Gross Margin9.95%16.97%22.28%21.68%25.07%24.21%21.60%25.57%24.34%25.76%22.52%20.36%
Operating Expense22.28M33.02M22.05M22.74M29.64M31.04M32.60M36.41M38.41M45.81M48.76M52.24M
Operating Income-7.46M-6.18M15.24M13.95M16.16M16.71M7.89M21.37M18.41M20.75M12.00M3.89M
Operating Margin-5.01%-3.91%9.11%8.24%8.84%8.47%4.21%9.46%7.89%8.03%4.45%1.41%
EBITDA----23.73M28.18M23.98M34.78M32.13M37.96M32.00M27.80M
EBITDA Margin----12.99%14.28%12.79%15.39%13.77%14.69%11.86%10.08%
Net Income-18.56M-15.77M3.47M2.63M10.76M7.59M3.92M15.05M6.85M8.08M1.78M-4.67M
Net Income Margin-12.47%-9.98%2.07%1.55%5.89%3.85%2.09%6.66%2.93%3.13%0.66%-1.69%
Interest Expense00006.37M6.28M6.14M6.55M7.63M9.33M10.70M11.35M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%3.48%3.18%3.28%2.90%3.27%3.61%3.97%4.12%

Balance Sheet

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets380.74M370.24M368.66M361.46M359.46M368.11M418.54M422.76M418.09M477.34M495.86M532.78M
Total Liabilities306.93M311.40M308.01M298.28M287.84M289.03M331.48M320.69M314.84M368.57M387.05M428.72M
Total Equity73.57M58.74M60.65M63.18M71.62M79.08M87.07M102.06M103.25M108.67M108.61M103.90M
Cash5.03M10.43M12.18M3.23M4.59M7.50M49.26M51.98M337.00K21.96M17.51M31.30M
Net Debt----127.83M114.56M86.17M81.45M111.68M118.40M108.88M129.18M

Cash Flow

Currency: EUR2007-12-312008-12-312009-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---3.58M12.89M9.78M-1.52M20.02M31.50M40.21M15.75M124.00K26.13M46.45M5.09M
Investing Cash Flow----2.17M-1.60M-3.75M-5.83M-7.86M-15.42M-7.11M-6.95M-15.78M---
Financing Cash Flow----12.87M-5.88M-4.26M-1.60M-10.80M-13.16M8.67M-6.07M-19.64M---
Capital Expenditure0003.00M2.01M3.77M5.83M7.96M16.27M7.08M11.28M15.87M22.35M26.63M16.92M
Free Cash Flow-------12.06M15.23M33.13M4.46M-15.75M3.78M19.82M-11.83M
Dividends Paid---58.00K58.00K35.00K55.00K81.00K39.00K141.00K81.00K-61.00K1.73M-
FCF to OCF-------60.24%48.35%82.40%28.35%-12701.61%14.47%42.67%-232.53%
Dividend Paid to FCF-------0.67%0.26%0.43%1.81%-1.61%8.72%-

Earnings

Report DateMay 30, 2008Nov 26, 2008Dec 2, 2009Jan 15, 2010May 21, 2010Aug 24, 2010Dec 1, 2010Mar 25, 2011May 20, 2011Aug 23, 2011Nov 30, 2011Mar 23, 2012May 18, 2012Aug 28, 2012Nov 28, 2012Mar 29, 2013May 24, 2013Aug 27, 2013Nov 27, 2013May 30, 2014Aug 29, 2014Nov 28, 2014May 29, 2015Aug 31, 2015Nov 30, 2015Mar 31, 2016Dec 31, 2017
EPS Estimate0.080.01-0.02-----------------------
EPS Actual0.070.04-0.02-0.010.03-0.01-0.08-0.100.01-0.08-0.13-0.020.13-0.03-0.03-0.15-0.02-0.01-0.040.010.03-0.060.04-0.07-0.07-0.08-0.03
Surprise-12.50%300.00%--150.00%-----------------------
TimingAfter-hoursAfter-hours-After-hours---------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap132.71M
Enterprise Value280.96M
Trailing P/E0.00
Forward P/E11.07
PEG Ratio0.93
Price / Sales0.48
Price / Book1.25
EPS-0.06
Book Value1.20
Revenue (TTM)275.75M
Gross Profit (TTM)56.14M
EBITDA19.69M
Profit Margin-1.69%
Operating Margin-0.10%
Return on Equity-4.34%
Return on Assets0.95%
Shares Outstanding86.74M
Shares Float50.96M
Beta0.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.07Aug 18, 2022
20091×
0.05Jul 6, 2009
20081×
0.06Jul 7, 2008
20071×
0.06Jul 5, 2007
20061×
0.04Jul 4, 2006
20051×
0.03Jul 1, 2005
20031×
0.04Jul 1, 2003
20021×
0.07Jul 1, 2002
20011×
0.10Jul 2, 2001
20001×
0.09Jul 3, 2000
19991×
0.08Jul 1, 1999
19981×
0.09Jul 1, 1998
19971×
0.10Jun 27, 1997
19961×
0.05Jul 1, 1996
19951×
0.05Jun 30, 1995
19941×
0.07Aug 1, 1994

Stock Splits

  • Feb 8, 20002511:1034
  • Mar 15, 19994997:4164
  • Jun 27, 19973:2
  • Aug 1, 19942:1